HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes. [electronic resource]
Producer: 20181105Description: 269-283 p. digitalISSN:- 1476-5462
- Animals
- Blood Glucose -- metabolism
- Diabetes Mellitus, Experimental -- genetics
- Diabetes Mellitus, Type 2 -- genetics
- Diet, High-Fat
- Disease Models, Animal
- Gene Transfer Techniques
- Glucose -- metabolism
- Glucose Intolerance
- Hep G2 Cells
- Humans
- Insulin -- metabolism
- Insulin Resistance -- physiology
- Insulin-Secreting Cells -- metabolism
- Lentivirus -- genetics
- Mice
- Mice, Inbred C57BL
- Obesity -- metabolism
- Vasoactive Intestinal Peptide -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.